Pharmaceuticals

Personalized Cancer Vaccines Market to Grow at a CAGR of 6.4% from 2025 to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Personalized Cancer Vaccines Market Size During 2025–2029?

The personalized cancer vaccines market size has shown substantial growth in recent years. It is anticipated to increase from $242.29 billion in 2024 to $256.65 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.9%. This expansion in the past can be linked to breakthroughs in genomic research, the creation of targeted therapies, a deeper insight into tumor immunology, improvements in vaccine technology, and accumulating clinical trial data that validates efficacy.

The personalized cancer vaccines market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $329.04 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the forecast period include advancements in precision medicine, increased funding for cancer research, a rising prevalence of cancer cases, enhancements in genetic sequencing technologies, and a heightened interest in customized treatment solutions. Key trends expected within the forecast period encompass the integration of artificial intelligence into vaccine design, breakthroughs in multi-antigen and neoantigen-based vaccines, a rise in the application of liquid biopsies for monitoring tumors, the broadening of combination therapies, and an intensified emphasis on tailored treatment regimens.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19136&type=smp

Which Factors And Drivers Are Influencing The Personalized Cancer Vaccines Market In 2025?

The rise in cancer cases is anticipated to drive expansion in the personalized cancer vaccine market moving ahead. Cancer is defined as a group of illnesses characterized by uncontrolled cell proliferation capable of spreading throughout the body. This growing incidence of cancer stems from factors such as an aging demographic, shifts in lifestyle, exposure to environmental contaminants, genetic vulnerabilities, and enhanced diagnostic methodologies. Personalized cancer vaccines play a role in mitigating the rising prevalence of cancer by targeting tumor antigens specific to individual patients, thereby boosting the immune system’s capacity to identify and eliminate malignant cells. For example, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in Australia, cancer diagnoses climbed from 160,570 in 2022 to 164,694 in 2023, showing a significant increase within that year. Consequently, the expanding occurrence of cancer is a key factor fueling the development of the personalized cancer vaccine market.

What Are The Segment Types Shaping The Personalized Cancer Vaccines Market?

The personalized cancer vaccines market covered in this report is segmented –

1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma

3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action

4) By Route Of Administration: Injectables, Other Routes Of Administration

5) By End Use: Hospitals, Clinic, Other End Users

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines

2) By Therapeutic Cancer Vaccines: Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines

How Are Trends Influencing The Personalized Cancer Vaccines Market?

Leading companies operating in the personalized cancer vaccine market are primarily focused on advancing therapeutic solutions, including personalized immunotherapy, to enhance the precision of treatment for specific cancer mutations. Personalized immunotherapy solutions represent customized treatments designed to utilize a patient’s unique genetic and tumor characteristics to bolster immune system responses against cancer. For example, in August 2024, UCLA Health, a healthcare organization based in the US, commenced a groundbreaking clinical trial to evaluate the safety and effectiveness of a new cancer vaccine. This vaccine, developed at UCLA, employs a personalized immunotherapy approach that specifically targets the H3 G34 mutation in diffuse hemispheric gliomas, an aggressive brain tumor commonly affecting adolescents and young adults. Its unique mechanism involves using dendritic cells to activate the immune system against the specific RNA disruptions induced by this mutation. The approach, which has shown promise in treating other cancers, aims to improve outcomes for patients who typically face limited treatment options and short survival times.

Who Are The Core Companies Influencing The Personalized Cancer Vaccines Market Landscape?

Major companies operating in the personalized cancer vaccines market are Merck & Co Inc., GlaxoSmithKline Plc, NEC Corporation, Moderna Inc., Catalent Inc., UCLA Health, Genetech Inc., NHS England, CureVac AG, Personalis Inc., Achilles Therapeutics Plc, Healio, Moffitt Corporation, BioPharma APAC, Celebrity Angels, EpiVax Therapeutics Inc., Evaxion Biotech AS, Geneos Therapeutics Inc., IFL Sciense, ISA Pharmaceuticals BV, Oxford Global, Kintara Therapeutics, VAXIMM Gmbh

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/personalized-cancer-vaccines-global-market-report

Which Geographies Are Emerging As Strong Markets For The Personalized Cancer Vaccines Industry?

North America was the largest region in the personalized cancer vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Personalized Cancer Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=19136&type=smp

Browse Through More Reports Similar to the Global Personalized Cancer Vaccines Market 2025, By The Business Research Company

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Cervical Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-vaccine-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795